Application no. and date | 09006110.2 (espacenet) (Federated) (European Patent Register), 20020827 | Patent/reg. no. and date | DK/EP 2092935, 20110330 | Publication date | 20090826 | Priority no. and date | US 315386 P, 20010828 | EP pub. no. and date |
EP 2092935 20090826 | Effective date | | Applicant/owner | Merck Sharp & Dohme LLC, 126 East Lincoln Avenue Rayway, New Jersey 07065, US | Applicant ref. no. | 10356-4 | Inventor | Sequeira, Joel A., 7 Centre Street Unit 2307
Ocean, NJ 07712, US, Hart, John L., 12 Cobble Lane
Bedminster, NJ 07921, US, Sharpe, Stefan A., 244 7th Street
Jersey City, NJ 07302, US | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | Opponent | | IPC Class | A61K 31/167 (2006.01) , A61K 31/58 (2006.01) , A61K 9/12 (2006.01) , A61P 11/06 (2006.01) | Title | Farmaceutiske sammensætninger til behandling astma | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|